New Public Health Chief Prioritizes mRNA Vaccines, Climate Resilience | Be Korea-savvy

New Public Health Chief Prioritizes mRNA Vaccines, Climate Resilience


The headquarters of the Korea Disease Control and Prevention Agency (Image courtesy of Yonhap)

The headquarters of the Korea Disease Control and Prevention Agency (Image courtesy of Yonhap)

SEOUL, July 16 (Korea Bizwire) — Im Seung-kwan, newly appointed as the fourth Commissioner of the Korea Disease Control and Prevention Agency (KDCA), pledged Monday to strengthen South Korea’s public health security infrastructure and position the agency as a central command hub for infectious disease crises.

Speaking at his inauguration ceremony at KDCA headquarters in Osong, Im outlined a vision focused on refining pandemic response systems, enhancing vaccine development capabilities, and addressing emerging challenges posed by climate change and demographic shifts.

“We must closely examine the shortcomings exposed during Korea’s COVID-19 response and move forward with improvements,” Im said, stressing the need for a robust, long-term national infectious disease response framework built on data platforms and strategic planning previously developed by KDCA.

Im highlighted the domestication of messenger RNA (mRNA) vaccine platforms as a priority, describing it as a “key to next-pandemic preparedness.” He also pledged to establish surveillance systems to monitor public health impacts from climate-related disasters such as heatwaves and floods, and to expand community-based frailty prevention programs in anticipation of Korea’s rapidly aging population.

KDCA’s New Leader Targets National Readiness for Next Pandemic (Image supported by ChatGPT)

KDCA’s New Leader Targets National Readiness for Next Pandemic (Image supported by ChatGPT)

On the global front, Im vowed to strengthen international cooperation and share South Korea’s best practices in health security, developed during the COVID-19 pandemic, to help tackle tuberculosis, malaria, and HIV, especially among vulnerable populations.

He also committed to improving chronic disease management through local health initiatives and to reinforcing national safeguards against health risks through the Injury Prevention Act, which takes effect this year.

A Seoul native and infectious disease specialist, Im holds undergraduate and master’s degrees from Ajou University School of Medicine. His previous roles include leading Gyeonggi Province’s COVID-19 emergency task force and serving as director of Anseong Hospital and the National Medical Center’s Infectious Disease Hospital Establishment Task Force.

M. H. Lee (mhlee@koreabizwire.com)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>